On ECHEMI
Home > Drugs > Zhejiang Zhongyi Pharmaceutical Co., Ltd.
Zhejiang Zhongyi Pharmaceutical Co., Ltd.
  • Founded in:

    2006-01-26
  • Country:

    China China
  • Address:

    No. 279, Lvgu Avenue, Shuige Industrial Zone, Zhejiang Province
  • Tax NO.:

    91331100773112151W
  • Registered Funds:

    40.5 million yuan
  • Email:

Related Drugs
Cediodine lozenges
The main ingredient of this product and its chemical name is molecular iodine.
Name Description Content CAS NO. Registered Holders
Molecular iodine

The rapid release of iodine molecules under the action of saliva can directly oxidize and halogenate bacterial proteins, and has a killing effect on a variety of bacterial reproductive bodies, fungi, spores, viruses, etc.

More

The rapid release of iodine molecules under the action of saliva can directly oxidize and halogenate bacterial proteins, and has a killing effect on a variety of bacterial reproductive bodies, fungi, spores, viruses, etc.

0
Potassium Magnesium Aspartate Tablets
Each tablet of this product contains 158 mg of potassium aspartate (C4H6NO4K) and 140 mg of magnesium aspartate [(C4Hshy;6NO4)2Mg].
Name Description Content CAS NO. Registered Holders
Potassium L-aspartate

Aspartic acid has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability and stability of the internal environment of nerve tissue, myocardium, smooth muscle and other cells. It can transport electrolytes to the myocardium, promote myocyte depolarization, maintain myocardial contractility, and reduce myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders.

More

Aspartic acid has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability and stability of the internal environment of nerve tissue, myocardium, smooth muscle and other cells. It can transport electrolytes to the myocardium, promote myocyte depolarization, maintain myocardial contractility, and reduce myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders.

158mg 14007-45-5 11
Magnesium L-aspartate

Aspartic acid participates in the ornithine cycle, promotes urea production, reduces ammonia and carbon dioxide levels in the blood, and enhances liver function.

More

Aspartic acid participates in the ornithine cycle, promotes urea production, reduces ammonia and carbon dioxide levels in the blood, and enhances liver function.

140mg 2068-80-6 7
Erythromycin Enteric-coated Capsules
The main ingredient of this product is erythromycin base.
Name Description Content CAS NO. Registered Holders
Erythromycin

This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus. Non-clinical toxicology studies: In long-term (2-year) studies on rats, there is no evidence of carcinogenicity or gene mutation after oral administration of erythromycin; studies on male and female rats.

More

This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus. Non-clinical toxicology studies: In long-term (2-year) studies on rats, there is no evidence of carcinogenicity or gene mutation after oral administration of erythromycin; studies on male and female rats.

114-07-8 43
Erythromycin Enteric-coated Capsules
The main ingredient of this product is erythromycin base.
Name Description Content CAS NO. Registered Holders
Erythromycin

This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus.

More

This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus.

114-07-8 43
Fenoprofen calcium tablets
The main ingredient of this product is fenoprofen calcium
Name Description Content CAS NO. Registered Holders
Fenoprofen calcium

It reduces the synthesis of prostaglandins by inhibiting cyclooxygenase, thereby alleviating tissue congestion and swelling and reducing the sensitivity of peripheral nerve pain. It has an antipyretic effect through the hypothalamic temperature regulation center.

More

It reduces the synthesis of prostaglandins by inhibiting cyclooxygenase, thereby alleviating tissue congestion and swelling and reducing the sensitivity of peripheral nerve pain. It has an antipyretic effect through the hypothalamic temperature regulation center.

53746-45-5 10
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.